LANLAN SHEN to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications LANLAN SHEN has written about Antimetabolites, Antineoplastic.
Connection Strength
0.185
-
Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood. 2008 Feb 15; 111(4):2382-4.
Score: 0.066
-
DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia. Cancer Res. 2006 May 15; 66(10):5495-503.
Score: 0.060
-
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer. 2006 Apr 15; 106(8):1794-803.
Score: 0.059